Spectral Medical Inc. (TSX:EDT)
Canada · Delayed Price · Currency is CAD 1.330
0.00 (0.00%)
Aug 27, 2026, 10:14 AM EST
Spectral Medical Revenue
Spectral Medical had revenue of 621.00K CAD in the quarter ending June 30, 2026, a decrease of -23.62%. This brings the company's revenue in the last twelve months to 2.57M, up 1.46% year-over-year. In the year 2025, Spectral Medical had annual revenue of 2.44M with 6.82% growth.
Revenue (ttm)
2.57M
Revenue Growth
+1.46%
P/S Ratio
151.98
Revenue / Employee
88.59K
Employees
29
Market Cap
390.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.44M | 156.00K | 6.82% |
| Dec 31, 2024 | 2.29M | 688.00K | 43.05% |
| Dec 31, 2023 | 1.60M | -69.00K | -4.14% |
| Dec 31, 2022 | 1.67M | -329.00K | -16.48% |
| Dec 31, 2021 | 2.00M | -105.00K | -5.00% |
| Dec 31, 2020 | 2.10M | -767.00K | -26.74% |
| Dec 31, 2019 | 2.87M | -972.00K | -25.31% |
| Dec 31, 2018 | 3.84M | 171.00K | 4.66% |
| Dec 31, 2017 | 3.67M | 124.00K | 3.50% |
| Dec 31, 2016 | 3.55M | 456.00K | 14.76% |
| Dec 31, 2015 | 3.09M | 125.00K | 4.22% |
| Dec 31, 2014 | 2.96M | 292.00K | 10.93% |
| Dec 31, 2013 | 2.67M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.20B |
| Extendicare | 1.98B |
| Green Thumb Industries | 1.72B |
| Sienna Senior Living | 1.08B |
| Cresco Labs | 924.67M |
| Aurora Cannabis | 314.07M |
| Auxly Cannabis Group | 165.57M |
| Cipher Pharmaceuticals | 70.47M |
Spectral Medical News
- 20 days ago - Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 20 days ago - Spectral Medical Registration statement: Q2 2026 - Filings
- 20 days ago - Spectral Medical Registration statement: Q2 2026 - Filings
- 20 days ago - Spectral Medical Earnings release: Q2 2026 - Filings
- 2 months ago - Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX - GlobeNewsWire
- 2 months ago - Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 3 months ago - Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial - GlobeNewsWire
- 3 months ago - Spectral Medical Announces PMA Submission to U.S. FDA for PMX - GlobeNewsWire